Guanxinjing ameliorates coronary microvascular dysfunction in myocardial ischemia-reperfusion injury by alleviating inflammation and restoring endothelial function - Summary - MDSpire

Guanxinjing Enhances Coronary Microvascular Function in Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation and Improving Endothelial Activity

  • By

  • Yaoting Wang

  • Lan Li

  • Liang Jin

  • Shikai Zhan

  • Hai Ren

  • Jiao Zhao

  • Qiuru Wang

  • Yiqiong Wang

  • Shudong Lin

  • Jiaxing Xin

  • Yao Dai

  • Yifan Zhou

  • Ting Zhang

  • Qian Liu

  • Yunyun Lu

  • Yiqi Zhu

  • Jiangyue Wu

  • Jiayan Lin

  • Shujing Zhang

  • Ling Zhang

  • July 17, 2026

Share

Objective:

To investigate the efficacy and mechanisms of Guanxinjing compound (GXJC) against myocardial ischemia-reperfusion injury (MIRI)-induced coronary microvascular dysfunction (CMD).

Approach:
  • Chemical Profiling: Performed using UHPLC-Q-Exactive HRMS to identify bioactive compounds in GXJC.
  • Network Pharmacology Analysis: Screened core targets and key pathways of GXJC, predicting the TNF signaling pathway as a potential mechanism.
  • In Vivo Studies: C57BL/6 mice received 7-day GXJC pretreatment before MIRI modeling, followed by evaluations using various staining and assessment techniques.
  • In Vitro Studies: Established a TNF-α-induced inflammatory injury model in HUVECs to dissect underlying mechanisms.
Key Findings:
  • Identified 256 bioactive compounds in GXJC.
  • GXJC treatment reduced myocardial infarct size and cardiomyocyte apoptosis.
  • Downregulated pro-inflammatory factors IL-6, IL-1β, and CCL2.
  • Modulated the eNOS/NO/ET-1 axis to alleviate endothelial dysfunction.
  • Lowered levels of FGL2 and p-selectin, reducing endothelial injury and thrombosis.
Interpretation:

Conclusion:

Original Source(s)

Related Content